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Abstract: In this study, we evaluated the effects of the extracts of the leaves of species from the Rubiaceae (Galium aparine L. and Asperula 
arvensis L.), Fabaceae (Lathyrus aphaca L. and Vicia narbonensis L.) and Poaceae (Digitaria sanguinalis (L.) Scop. and Hordeum murinum L.) 
plant families on a wide and extensive panel of isolated methicillin-resistant Staphylococcus aureus strains (MRSA). The effects of the methano-
lic leaf extracts of Rubiaceae, Fabaceae and Poaceae plants on MRSA were evaluated by the disc diffusion assay and the broth dilution method. 
Among a total of 177 S. aureus isolates, 92 (51.97%) were found to be methicillin-resistant in an antibiogram and this was confirmed by the 
presence of the mecA gene in polymerase chain reaction method. All MRSA isolates were sensitive to all extracts. There were dose-dependent 
inhibitions on tested microorganisms for all plant extracts which showed maximum inhibition zones at a concentration of 300 mg/L. L. aphaca, 
G. aparine and H. murinum exhibited the highest antibacterial activity on the MRSA strains compared to the positive control (P < 0.05), as well 
as higher total polyphenol and flavonoid contents than other plant extracts. Minimum inhibitory concentrations on MRSA isolates ranged from 
388.4 ± 0.2 mg/L, in D. sanguinalis, to L. 5.5 ± 0.1 mg/L, in L. aphaca. The methanolic extracts of L. aphaca (Fabaceae), G. aparine (Rubia-
ceae), and H. murinum (Poaceae) proved to have high antibacterial activity on MRSA isolates, thus representing promising antimicrobial agents 
in clinical settings.
Key words: Antibiotic resistance, antibiotic therapy, nosocomial infections, medicinal plants, total polyphenol content, total flavonoid content.
Introduction
Methicillin resistant Staphylococcus aureus (MRSA) 
was first identified almost 50 years ago shortly after the 
introduction of the antibiotic methicillin (1). MRSA 
infections are caused by S. aureus strains resistant to a 
number of antibiotics; they are highly contagious and 
can be spread through direct contact with an infected 
person. Infection can also be contracted by coming into 
contact with an object or surface that an infected person 
has touched. MRSA infections are classified as either 
hospital-acquired (HA-MRSA) or community-acquired 
(CA-MRSA). HA-MRSA is associated with infections 
that are contracted in healthcare settings such as hos-
pitals or nursing homes. It can cause severe problems, 
such as septicemia and pneumonia. CA-MRSA is asso-
ciated with infections that are transmitted through close 
personal contact with an infected person or through di-
rect contact with an infected wound. This type of MRSA 
infection may also develop as a result of poor hygiene 
such as infrequent or improper hand-washing (2). In 
spite of the fact that superficial skin and soft tissue in-
fections remain the most common manifestation of CA-
MRSA, severe diseases such as necrotizing fasciitis, 
necrotizing pneumonia, pyomyositis, septic embolism, 
venous thrombosis, and osteomyelitis have been des-
cribed and previously caused death in healthy children 
(3,4). Despite the availability of new antibiotics, MRSA 
continues to threaten the world population. Therefore, 
there is a continuous necessity for novel antimicrobial 
compounds due to the rapid appearance of MRSA (5, 6).
In developing countries, due to economic constraints, 
nearly 80% of the population still depends on plant ex-
tracts as a source of natural remedies (7). Nevertheless, 
though plants are greatly exploited in traditional healing 
systems, only in some cases their therapeutic potential 
in human has been substantiated (8-10). The need of 
herb-based medicines, cosmetics, food supplements, 
pharmaceuticals and health products is progressively 
increasing all over the world, because, in some cases, 
natural products i) are non or low toxic, ii) show low 
side effects and iii) are available at affordable costs (11). 
Not the least, plant extracts can reduce the occurrence of 
resistant microbial strains because they consist of many 
bioactive phytochemicals with different molecular and 
biochemical targets.
Plants are historically used to treat infectious di-
seases. In addition, antimicrobial compounds from 
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plants may be effective in counteracting infections 
caused by antibiotic-resistant bacterial strains (12-14). 
Due to the increasing phenomenon of bacterial resis-
tance to antibiotics, in this study, we investigated the in 
vitro antibacterial activity of Rubiaceae (Galium apa-
rine L. and Asperula arvensis L.), Fabaceae (Lathyrus 
aphaca L. and Vicia narbonensis L.) and Poaceae (Digi-
taria sanguinalis (L.) Scop. and Hordeum murinum L.) 
plants against MRSA bacterial strains, in order to find 
new strategies to control antibiotic-resistant bacteria.
Materials and Methods
Plants and extraction
The leaves of Rubiaceae (Galium aparine L. and 
Asperula arvensis L.), Fabaceae (Lathyrus aphaca L. 
and Vicia narbonensis L.) and Poaceae (Digitaria san-
guinalis (L.) Scop. and Hordeum murinum L.) plants 
(Table 1) were collected between April-May 2013 from 
the area of Hamun Lake of Zabol, Sistan and Balu-
chestan Province, Iran. The specimens were identified 
by a plant taxonomist at the Department of Pharmaco-
gnosy, Faculty of Pharmacy, Zabol University of Medi-
cal Sciences, Zabol, Iran. The plant leaves were dried 
in an oven at 60 °C for 72 h. Twenty grams of leaves 
for each plant were powdered separately and then sus-
pended in 200 mL of methanol 80%, water 20% using 
a shaker water bath for 24 h at 25 °C. After filtration 
with Whatman No. 1 filter paper, the resulting solutions 
were concentrated by a rotary evaporator at 40 °C for 35 
min to remove solvent from the extracts. Solid extracts 
(residues of plant extracts) were stored at -20 °C until 
further analyses.
Total phenol content
Total phenols were assayed based on the method of 
Dewanto et al. (15). An aliquot of each diluted extract 
was added to 0.5 mL of distilled water and 0.125 mL of 
Folin-Ciocalteu reagent. The mixture was shaken and 
allowed to stand for 10 min, before addition of 1.25 mL 
of 5% Na2CO3. The solutions were then adjusted with 
distilled water to a final volume of 4 mL and mixed tho-
roughly. Absorbance at 760 nm was read versus blank 
after incubation in the dark. The total phenol concentra-
tion of each plant was expressed as milligrams of gal-
lic acid equivalents per gram of dry weight (mg GAE/g 
DW) from a calibration curve with gallic acid.
Total flavonoid content
The colorimetric assay was used for the assay of 
total flavonoids according to Dewanto et al. (15). An 
aliquot of diluted sample or standard solution of (+)-ca-
techin was added to 50 mL of NaNO2 solution (5%) and 
mixed for 5 min before the addition of 0.15 mL AlCl3 
(10%). After 5 min, 0.5 mL of NaOH was added. The 
final volume was adjusted to 2.5 mL with distilled water 
and mixed thoroughly. Absorbance was determined at 
510 nm against blank. The total flavonoid concentration 
was expressed as milligrams of catechin per gram of dry 
weight (mg CE/g DW) against the calibration curve of 
(+)-catechin, from 0 to 400 mg/L.
Bacterial isolation and culturing
One hundred and seventy-seven clinical specimens 
including burns, wounds, urines, pus, and throat swabs 
were collected from patients who attended the emer-
gency Hospital and Internal Laboratory of Hospital and 
Central Laboratory in Zabol, Iran, for different infec-
tions. Standard isolation protocols were used for all the 
samples. Identification of Staphylococcus aureus was 
approved by standard techniques accord to diagnostic 
tests, such as catalase test, culturing on mannitol salt 
agar, coagulase tube test and DNase.
Determination of MRSA isolates and antibiotic sus-
ceptibility
For MRSA differentiation from other S. aureus iso-
lates, Muller Hinton Agar medium (Oxoid Oxoid Ltd, 
UK) was used. The strains in a liquid medium of 0.5 
McFarland standard concentrations were grown in 
Muller Hinton Agar medium and antibiotic discs with 
ampicillin (10 μg), erythromycin (15 μg), penicillin (10 
U), ciprofloxacin (5 μg), clindamycin (2 μg), vancomy-
cin (30 μg), methicillin (5 μg) and gentamycin (10 μg) 
(Mast Group Ltd, UK) were placed on the medium and 
incubated for 24 h at 37 °C (16). Then, the diameter of 
the clear zone around the discs was measured by stan-
dards of Clinical Laboratory Standard Institute (17).
DNA extraction, polymerase chain reaction (PCR) 
assay and electrophoresis
For DNA extraction the phenol-chloroform method 
was used (18). DNA extracted samples were dissolved 
in Tris acetate-ethylenediaminetetraacetic acid (Tris-
EDTA) buffer (HCl 10 mM Tris, 1 mM EDTA, pH = 
7.4), and DNA concentration (µg/mL) was determined 
by a spectrophotometer at A
260
. The quantity of DNA 
samples used ranged from 10 to 1000 ng. DNA obtained 
was conserved at -20 °C for further assays.
All MRSA isolates were tested for the presence of 
the mecA gene by polymerase chain reaction (PCR) 
using previously described primers (19, 20). The stan-
dard strain used for MRSA was S. aureus ATCC14458; 
distilled water was used as the negative control. For 
PCR, forward and reverse primers (mecA-1 GTGAA-
GATATACCAAGTGATT; mecA-2 ATGCGCTATA-
GATTGAAAGGAT) were diluted to reach a concentra-
tion of 100 pM. After preparing the PCR mix, amplifica-
tions were performed. PCR products were mixed with 1 
µL of loading buffer solution and carefully loaded in the 
wells of the agarose gel (1.5%) and electrophoresed at 
75 V for 90 min. The gel was then stained with ethidium 
bromide (Merck, Germany) solution for 15 min and ob-
served under a UV transilluminator (UV doc, England).
Disc diffusion assay
Antimicrobial tests were carried out by the disc 
diffusion method using 100 μL of bacteria suspension 
(containing 2.0 × 108 CFU/mL of bacteria) dispersed on 
Mueller-Hinton agar in sterilized Petri dishes (60 mm in 
diameter). To the discs (6 mm in diameter, HI Media La-
boratories Pvt. Ltd., Mumbai, India) placed on the ino-
culated agar 10, 25, 50, 100, 150, and 300 mg/L of each 
leaf plants extracts were added. The inoculated plates 
were maintained at 4 °C for 2 h and later incubated at 
37 °C for 24 h. Antimicrobial activity was determined 
by measuring the zone of inhibition (mm) against the 
test bacterial (MRSA isolates and MRSA ATCC14458). 
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Distilled water and vancomycin (30 µg) were used as 
negative control and positive control, respectively.
Determination of minimum inhibitory concentration
For determination of minimum inhibitory concentra-
tion (MIC) the broth dilution method was used: 500 µL 
of 24 h culture of the test organisms (108 CFU/mL) ad-
justed to McFarland’s turbidity standard, were incuba-
ted in distilled water for 24 h at 37 °C in serial dilutions 
ranging from 3.9 to 500 mg/L of each plant extract. The 
concentration of the lowest dilution with no detectable 
bacterial growth was considered as the MIC. Growth 
absence was confirmed by the absence of turbidity and 
inoculation into agar (21).
Statistical analysis
Diameters of inhibition zones caused by each plant 
extracts and MICs on different bacteria were analyzed 
by SPSS v11. Data were compared by one-way ANOVA 
and Dunnett’s post hoc test. P values less than 0.05 were 
considered as statistically significant. Each test was per-
formed with three replicates.
Results
The total polyphenol and flavonoid contents in 
methanol leaf extracts are shown in Table 2. Total po-
lyphenols in G. aparine, A. arvensis, L. aphaca, V. nar-
bonensis, D. sanguinalis and H. murinum leaf extract 
were 76.4 ± 0.2, 8.4 ± 1.1, 160.2 ± 0.5, 6.75 ± 0.2, 4.8 ± 
0.3, and 65.9 ± 0.5 GAE/g DW, respectively. Flavonoid 
contents were 83.7 ± 1.2, 5.5 ± 0.2, 94.6 ± 0.4, 3.9 ± 0.4, 
2.3 ± 0.1, and 31.3 ± 0.2 GAE/g DW for G. aparine, A. 
arvensis, L. aphaca, V. narbonensis, D. sanguinalis and 
H. murinum leaf extracts, respectively.
Antibiotic resistance/sensitivity of MRSA isolates 
is reported in Table 3. Ninety-two (51.97%) out of 177 
isolates were found to be methicillin-resistant in the 
antibiogram. In the antibiotic profile of MRSA strains, 
very high resistance was observed against ampicillin, 
penicillin and methicillin (100%). A lower degree of 
resistance was observed against the other antibiotics 
(ciprofloxacin, clindamycin, erythromycin and genta-
mycin). In addition, 6 isolates were resistant to vanco-
mycin (Table 3). These results were confirmed by the 
presence of mecA gene in the 92 isolates, as indica-
ted by the 147 bp fragment observed in electrophore-
sis (Figure 1). The results of the disk diffusion assay, 
i.e. the inhibition zones of each plant extract, negative 
control (water) and positive control (vancomycin 30 
μg/disc) are shown in Tables 4, 5, and 6. There were 
Plant name Total phenolic content (GAE/g DW)# Total flavonoid content (mg CE/g DW)†
Galium aparine L. 76.4 ± 0.2 b§ 83.7 ± 1.2 b
Asperula arvensis L. 8.4 ± 1.1 d 5.5 ± 0.2 d
Lathyrus aphaca L. 160.2 ± 0.5 a 94.6 ± 0.4 a
Vicia narbonensis L. 6.75 ± 0.2 e 3.9 ± 0.4 e
Digitaria sanguinalis (L.) Scop. 4.8 ± 0.3 f 2.3 ± 0.1 f
Hordeum murinum L. 65.9 ± 0.5 c 31.3 ± 0.2 c
Antibiotics Number of isolatesSensitive Moderate Resistant
Ampicillin 0 0 92
Ciprofloxacin 60 0 32
Penicillin 0 0 92
Clindamycin 44 2 46
Methicillin 0 0 92
Erythromycin 65 0 27
Vancomycin 86 0 6
Gentamycin 52 0 40
Table 3. Antibiotic susceptibility of Staphylococcus aureus isolates.
#Gallic acid equivalents per gram of dry weight.
†Milligrams of catechin per gram of dry weight.
§Values are expressed as mean ± SD; different letters show significant differences for each plant in each column at a P < 0.05.
Figure 1. Patterns of agarose gel electrophoresis showing PCR 
amplification products for methicillin-resistant Staphylococcus au-
reus (MRSA) isolates. Lane M: DNA 100 basepair molecular size 
marker; lane 1: MRSA isolate; lane C+: positive control (reference 
strain S. aureus ATCC14458); lane C-: negative control.
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dose-dependent inhibitions on tested microorganisms 
for all plant extracts. All extracts exhibited maximum 
inhibition at 300 mg/L on MRSA isolates and standard 
strain (S. aureus ATCC14458). Inhibition haloes on 
MRSA isolates at 300 mg/L of G. aparine, A. arven-
sis, L. aphaca, V. narbonensis, D. sanguinalis and H. 
murinum leaf extracts were 29.3 ± 0.2, 9.9 ± 0.6, 65.5 ± 
0.4, 8.8± 0.2, 5.4 ± 0.1 and 25.5 ± 0.3 mm in diameter, 
respectively. The standard strain showed smaller zones 
of inhibition than the MRSA isolates, and diameters of 
Extract concentration (mg/L) MRSA isolates S. aureus (ATCC14458)
Galium aparine L.
10 6.3 ± 0.0 g 5.5 ± 0.4 g
25 14.5 ± 0.2 f 12.4 ± 0.1 f
50 16.5 ± 0.0 e 15.8 ± 0.5 e
100 21.4 ± 0.1 c 22.1 ± 0.0 c
150 25.9 ± 0.4 b 24.5 ± 0.3 b
300 29.3 ± 0.2 a 27.8 ± 0.5 a
Negative control (distilled water) 0.0 ± 0.0 h 0.0 ± 0.0 h
Positive control (vancomycin 30 µg) 18.5 ± 0.1 d 19.8 ± 0.5 d
MIC (mg/L) 65.5 ± 0.3 77.9 ± 0.5
Asperula arvensis L.
10 0.0 ± 0.0 f 0.0 ± 0.0 f
25 0.0 ± 0.0 f 0.0 ± 0.0 f
50 3.5 ± 0.1 e 2.2 ± 0.2 e
100 6.6 ± 0.4 d 5.5 ± 0.3 d
150 8.7 ± 0.5 c 7.9 ± 0.6 c
300 9.9 ± 0.6 b 8.5 ± 0.4 b
Negative control (distilled water) 0.0 ± 0.0 f 0.0 ± 0.0 f
Positive control (vancomycin 30 µg) 18.5 ± 0.1 a 19.8 ± 0.5 a
MIC (mg/L) 245.4 ± 0.2 264.3 ± 0.2
Table 4. Inhibition zones of Rubiaceae plant extracts on MRSA isolates.
Data are expressed as mean ± SD of the inhibition zone diameter (mm) for different concentrations of plant extracts and controls; the values with 
different letters within a column are significantly different (P < 0.05); MIC: minimum inhibitory concentration.
Extract concentration (mg/L) MRSA isolates S. aureus (ATCC14458)
Lathyrus aphaca L.
10 11.5 ± 0.3 g 10.3 ± 0.2 g
25 17.7 ± 0.3 f 16.9 ± 0.1 f
50 28.4 ± 0.1 d 26.8 ± 0.5 d
100 37.5 ± 0.2 c 37. 6 ± 0.3 c
150 48.6 ± 0.5 b 47.5 ± 0.2 b
300 65.5 ± 0.4 a 63.3 ± 0.1 a
Negative control (distilled water) 0.0 ± 0.0 h 0.0 ± 0.0 h
Positive control (vancomycin 30 µg) 18.5 ± 0.1 e 19.8 ± 0.5 e
MIC (mg/L) 5.5 ± 0.1 7.8 ± 0.3
Vicia narbonensis L.
10 0.0 ± 0.0 e 0.0 ± 0.0 e
25 0.0 ± 0.0 e 0.0 ± 0.0 e
50 0.0 ± 0.0 e 0.0 ± 0.0 e
100 4.3 ± 0.1 d 3.3 ± 0.2 d
150 5.5 ± 0.3 c 4.7 ± 0.5 c
300 8.8 ± 0.2 b 7.8 ± 0.5 b
Negative control (distilled water) 0.0 ± 0.0 e 0.0 ± 0.0 e
Positive control (vancomycin 30 µg) 18.5 ± 0.1 a 19.8 ± 0.5 a
MIC (mg/L) 288.3 ± 0.1 299.5 ± 0.4
Data are expressed as mean ± SD of the inhibition zone diameter (mm) for different concentrations of plant extracts and controls; the values with 
different letters within a column are significantly different (P < 0.05); MIC: minimum inhibitory concentration.
Table 5. Inhibition zones of Fabaceae plant extracts on MRSA isolates.
Data are expressed as mean ± SD of the inhibition zone diameter (mm) for different concentrations of plant extracts and controls; the values with 
different letters within a column are significantly different (P < 0.05); MIC: minimum inhibitory concentration.
Table 6. Inhibition zones of Poaceae plant extracts on MRSA isolates.
Extract concentration (mg/L) MRSA isolates S. aureus (ATCC14458)
Digitaria sanguinalis (L.) Scop.
10 0.0 ± 0.0 e 0.0 ± 0.0 e
25 0.0 ± 0.0 e 0.0 ± 0.0 e
50 0.0 ± 0.0 e 0.0 ± 0.0 e
100 3.5 ± 0.2 d 3.2 ± 0.1 d
150 4.8 ± 0.3 c 3.5 ± 0.2 c
300 5.4 ± 0.1 b 4.8 ± 0.5 b
Negative control (distilled water) 0.0 ± 0.0 e 0.0 ± 0.0 e
Positive control (vancomycin 30 µg) 18.5 ± 0.1 a 19.8 ± 0.5 a
MIC (mg/L) 388.4 ± 0.2 394.9 ± 0.5
Hordeum murinum L.
10 4.5 ± 0.3 g 4.4 ± 0.2 g
25 12.9 ± 0.3 f 11.5 ± 0.0 f
50 14.7 ± 0.5 e 14.8 ± 0.3 e
100 19.5 ± 0.3 c 18.8 ± 0.5 d
150 22.7 ± 0.4 b 20.4 ± 0.2 b
300 25.5 ± 0.3 a 24.5 ± 0.1 a
Negative control (distilled water) 0.0 ± 0.0 h 0.0 ± 0.0 h
Positive control (vancomycin 30 µg) 18.5 ± 0.1 d 19.8 ± 0.5 c
MIC (mg/L) 83.8 ± 0.2 96.7 ± 0.8
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inhibition haloes were 27.8 ± 0.5, 8.5 ± 0.4, 63.3 ± 0.1, 
7.8 ± 0.5, 4.8 ± 0.5 and 24.5 ± 0.1 mm for G. aparine, 
A. arvensis, L. aphaca, V. narbonensis, D. sanguinalis 
and H. murinum leaf extracts, respectively. The posi-
tive control (vancomycin) showed inhibition zones of 
18.5 ± 0.1 and 19.8 ± 0.5 mm on MRSA isolates and 
the standard strain, respectively. Among all plants, the 
inhibition zones of G. aparine, L. aphaca and H. muri-
num were more significantly different than the positive 
control (P < 0.05).
The results of the broth dilution test of plant extracts 
are shown in Tables 4, 5, and 6. MICs on MRSA iso-
lates were 65.5 ± 0.3, 245.4 ± 0.2, 5.5 ± 0.1, 288.3 ± 
0.1, 388.4 ± 0.2 and 83.8 ± 0.2 mg/L for G. aparine, 
A. arvensis, L. aphaca, V. narbonensis, D. sanguinalis 
and H. murinum leaf extracts, respectively. The MICs 
of the extracts against the standard S. aureus strain were 
77.9 ± 0.5, 264.3 ± 0.2, 7.8 ± 0.3, 299.5 ± 0.4, 394.9 ± 
0.5 and 96.7 ± 0.8 mg/L for G. aparine, A. arvensis, L. 
aphaca, V. narbonensis, D. sanguinalis and H. murinum 
leaf extract, respectively and these values were higher 
than the MICs of the MRSA isolates.
For all the plant extracts, a correlation analysis based 
on simple linear regression was performed on the as-
sayed variables (total polyphenol content and total fla-
vonoid content vs. MIC) at the 95% confidence level 
(Figure 2A,B). Both polyphenols and flavonoids were 
highly correlated with MIC values, with high linear cor-
relation coefficients (R2 = 0.787 and R2 = 0.776, respec-
tively).
Discussion
The results of our study illustrated that plants with 
higher levels of total polyphenols and flavonoids in 
the methanol leaf extracts, i.e. L. aphaca (Fabaceae), 
G. aparine (Rubiaceae) and H. murinum (Poaceae), 
showed higher antibacterial activity against the MRSA 
strains (Figure 2). Antimicrobial activity of plant phe-
nolics, including flavonoids, has been demonstrated 
since decades (22, 23). Eight flavonoids were isolated 
in the whole plant of G. aparine: chrysoeriol, apige-
nin, luteolin, quercetin, chrysoeriol-7-O-β-D-glucoside, 
apigenin-7-O-β-D-glucoside, luteolin-4′-O-β-D-
glucoside and luteolin-7-O-β-D-glucoside (24). More 
recently, other phenolic compounds were identified in 
this species, such as coumarin, esculetin, chlorogenic 
acid, cinnamic acid, p-coumaric acid and quercitrin 
(25). Two iridoid glycosides were also isolated from 
the aerial parts of G. aparine, asperulosidic acid and 
10-deacetylasperulosidic acid (26), as well as lipophilic 
compounds including fatty acids, phytosterols, sesqui-
terpenoinds and other isoprenoids (27, 25, 28). In a pre-
vious study, a tincture of G. aparine showed a mild inhi-
bitory activity on S. aureus, producing an average zone 
of inhibition of 2 mm (29). Conversely, S. aureus and 
Pseudomonas aeruginosa were highly sensitive to the 
lipophilic extract of this plant (27). Anticancer activity 
of G. aparine was also reported in leukemia and breast 
cancer cells (25, 28). A number of flavonoid, namely la-
rycitrin, syringetin-3-O-rutinoside-7-O-β-D-glucoside, 
quercetin and quercetin-3-O-β-D-glucoside were found 
in different tissues (leaves, flowers, seeds and pod) of L. 
aphaca (30, 31). Noteworthy, the butanol extract of L. 
aphaca seeds exhibited inhibitory activity on S. aureus, 
Escherichia coli and Klebsiella pneumoniae, with MICs 
of 76.25, 90.50 and 98.50 µg/mL, respectively (32). To 
the best of our knowledge, no information is available 
on phytochemical profile (in terms of polyphenols or 
flavonoids) and biological activities of H. murinum.
As regards other species, flavonoids isoquercitrin, 
hyperin, quercetin-7-O-β-D-galactoside, quercetin-4’-
O-β-D-galactoside, isorhamnetin-3-O-β-D-galactoside, 
isorhamnetin-5-O-β-D-galactoside, dihydrokaempfero-
7-4’-dimethylether-3-O-β-D-glucoside and 
isorhamnetin-3-O-α-D-ramnosil-(1’’’→6’’)- β-D-
glucoside were identified in the aerial parts of A. arven-
sis (33). Similarly, a number of quercetin and kaempfe-
rol glycosides were isolated from V. narbonensis fruits 
and leaves (34), whereas veratric acid (a phenolic com-
pounds), maltol and loliolide (a monoterpene lactone) 
were found in D. sanguinalis (35).
In conclusion, this study provides new information 
on the antimicrobial potential of L. aphaca (Fabaceae), 
G. aparine (Rubiaceae), and H. murinum (Poaceae) to 
MRSA strains. As known, mecA gene encodes the pro-
tein PBP2A (penicillin binding protein 2A) in the bacte-
rial cell wall with a low affinity for β-lactam antibiotics 
(36). In this view, it will be pivotal to investigate the 
mechanism(s) involved in the observed phenomena, in 
order to develop new, promising antibacterial agents.
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